BIRNA

Research · Microbiome

Microbiota at the intestinal interface

Interface · Sensing · Host–microbial communication

Birna Ásbjörnsdóttir, PhDResearch synthesis / scientific explainer

Evidence classification: Mechanistic · Experimental animal model · Editorial synthesis

The intestinal microbiota does not interact with the host across an empty space.

Between the dense microbial communities of the intestinal lumen and the internal environment lies a highly organised mucosal interface: mucus, antimicrobial molecules, secretory immunoglobulins, epithelial cells, immune cells, microbial metabolites and the physical and chemical gradients that determine where microorganisms can live.¹–⁴

This interface is neither a sterile boundary nor a site of unrestricted contact.

It is a regulated ecological zone.

The host must tolerate and, in many cases, support an enormous microbial population while limiting microbial access to tissues where that population would become harmful. At the same time, epithelial and immune cells continually receive information generated by microorganisms and their products.²–⁵

The relationship is therefore not adequately described as a battle between host and microbes.

Nor is it simply coexistence.

It is a continuous process of spatial organisation, sensing, signalling and response.

Understanding the microbiota at the intestinal interface requires us to ask not only which microorganisms are present, but how close they are to the host, what reaches the epithelial surface, how the host senses those signals and how both sides alter the environment in which the interaction occurs.

Distance is biologically meaningful

Microbial density increases dramatically along the gastrointestinal tract and is greatest in the colon.

Yet even there, microorganisms are not distributed uniformly.

The colonic mucus system creates an important degree of spatial separation between the dense luminal microbiota and the epithelial surface. In the healthy colon, the inner mucus layer forms a structured barrier that restricts penetration by most bacteria, while the outer mucus layer provides a habitat and nutrient source for microbial communities.¹,²

This organisation matters because the biological consequences of a microorganism depend partly on where it is.

A bacterium in the intestinal lumen is not necessarily equivalent to the same organism in close association with the mucosa.

Microbial molecules released near the epithelial surface may encounter host receptors at concentrations different from those measured in faeces.

Likewise, a compositional change detected in stool does not establish that the same change occurred within the mucosa-associated community.⁶,⁷

Spatial organisation is therefore part of function.

Presence without location is incomplete biological information.

Mucus is part of the ecological system

Mucus is often described primarily as a protective coating.

Its role is more complex.

Mucins create a physical and biochemical environment that helps organise microbial communities and regulate access to the epithelial surface.¹,²,⁸ Mucus also provides glycans that some intestinal microorganisms can utilise as nutrients.

This creates a reciprocal relationship.

The host produces the mucus environment.

Microorganisms influence its composition and turnover.

Some microorganisms specialise in degrading mucin-associated glycans, releasing products that can subsequently be used by other members of the community.⁸,⁹

Under appropriate ecological conditions, this can form part of normal microbial metabolism.

Under other conditions, excessive utilisation of the mucus layer — particularly when dietary substrates are limited — may reduce the distance between microorganisms and the epithelium and alter susceptibility to inflammatory or infectious challenge.⁹

The same microbial activity can therefore have different consequences depending on substrate availability and ecological context.

The epithelium is a sensing surface

Intestinal epithelial cells are not passive bricks in a barrier wall.

They are active participants in host–microbial communication.

Epithelial cells express receptors capable of recognising microbial structures and responding to microbial products. These include pattern-recognition systems such as Toll-like receptors and NOD-like receptors, alongside receptors responsive to microbial metabolites and host-derived signals.³–⁵,¹⁰

Recognition does not automatically trigger inflammation.

This is crucial.

The healthy intestinal epithelium exists in continuous proximity to microbial molecules. If every microbial signal were interpreted as an emergency, chronic inflammation would be unavoidable.

Instead, epithelial responses are shaped by location, receptor distribution, signal strength, cellular state and the surrounding immune environment.³–⁵

The same broad class of microbial molecule can therefore produce different outcomes depending on where and how it is encountered.

Host–microbial sensing is contextual.

Recognition and tolerance coexist

The intestinal immune system faces an unusual biological problem.

It must remain capable of responding to invasive organisms while avoiding destructive responses to food antigens and the resident microbiota.

This requires more than simple suppression of immunity.

It requires discrimination.

Secretory immunoglobulin A contributes to this organisation by binding microorganisms and microbial antigens within the lumen and mucus, influencing microbial localisation and interactions with the mucosal surface.¹¹,¹²

Innate lymphoid cells, macrophages, dendritic cells and adaptive lymphocytes contribute additional layers of surveillance and regulation.³,¹³,¹⁴

Regulatory immune pathways help maintain tolerance, while inflammatory pathways remain available when spatial boundaries are breached or tissue damage occurs.

The resulting state is dynamic.

Tolerance is not ignorance of the microbiota.

It is an actively maintained relationship.

Antimicrobial molecules help shape microbial geography

The epithelium also contributes directly to microbial spatial organisation through antimicrobial peptides and proteins.

Paneth cells in the small intestine produce antimicrobial molecules including defensins, while epithelial cells elsewhere contribute additional antimicrobial factors.¹⁵,¹⁶

These molecules do more than kill microorganisms indiscriminately.

They help establish ecological gradients and restrict microbial access to particular niches.

Their production can itself be influenced by microbial and immune signals, creating another feedback loop between the host and the microbial community.¹⁵,¹⁶

The intestinal interface is therefore partly constructed by the host in response to the organisms inhabiting it.

Microbial ecology and host defence are intertwined.

Oxygen helps define the interface

One of the most important ecological gradients at the intestinal surface is oxygen.

The colonic lumen is predominantly anaerobic, supporting organisms adapted to low-oxygen conditions. The epithelial surface lies closer to oxygenated host tissue, creating a steep radial oxygen gradient.¹⁷,¹⁸

Healthy colonocytes contribute to maintaining this environment through their metabolism.

Butyrate produced by anaerobic microbial fermentation can serve as an important fuel for colonocytes. Oxidative metabolism of butyrate consumes oxygen and helps maintain epithelial hypoxia, thereby limiting oxygen diffusion into the lumen.¹⁷,¹⁹

This creates an elegant host–microbial feedback system.

Anaerobic microorganisms produce metabolites.

The host uses those metabolites.

Host metabolism then helps preserve the anaerobic environment that favours those microbial communities.

When epithelial metabolism or inflammatory conditions alter this oxygen landscape, facultative anaerobes such as members of the Enterobacteriaceae can gain a competitive advantage.¹⁷–²⁰

What may appear as “dysbiosis” can therefore be partly understood as an ecological response to altered host physiology.

Inflammation changes microbial habitat

Inflammation does not simply respond to microbial communities.

It changes the environment in which they live.

Inflammatory responses can alter epithelial metabolism, oxygenation and the availability of electron acceptors. These changes can favour organisms capable of exploiting the new chemical environment.¹⁸,²⁰,²¹

This creates the possibility of feedback.

Inflammation alters the habitat.

The altered habitat favours different microorganisms.

Those microorganisms or their products may then reinforce inflammatory processes.

In such a system, asking whether dysbiosis caused inflammation or inflammation caused dysbiosis may be too simple.

Both processes can become coupled.

This is why microbial differences observed in inflammatory disease cannot automatically be interpreted as primary causes.

The ecological environment has changed.

Microbial metabolites cross the conceptual boundary

Many host–microbial interactions do not require microorganisms themselves to cross the epithelial barrier.

Microbial metabolites can act locally at the mucosal surface or be absorbed into host circulation.

Short-chain fatty acids, secondary bile acids and tryptophan-derived metabolites are among the best studied examples.²²–²⁴

These molecules can interact with epithelial and immune receptors, influence cellular metabolism and alter gene expression.

Their effects depend on concentration, location, receptor expression and physiological context.

This provides an important conceptual correction.

Host–microbial communication is not equivalent to microbial translocation.

A healthy interface is permeable to information.

Indeed, communication across the interface is part of normal physiology.

The biological problem is not to prevent all microbial influence.

It is to regulate which signals cross, in what form and with what consequence.

Barrier integrity does not mean microbial isolation

The language of barrier integrity can unintentionally suggest that a successful intestinal barrier isolates the host from its microbiota.

That is not what the biology shows.

Microbial metabolites are sensed.

Microbial molecular patterns are detected.

Secretory antibodies interact with microbial communities.

Epithelial cells alter antimicrobial programmes in response to microbial signals.

Immune cells sample and respond to the intestinal environment.³–⁵,¹¹–¹⁶

The barrier maintains compartmentalisation while permitting communication.

This distinction is central to the concept of a living barrier.

A wall is successful when nothing crosses it.

A biological interface is successful when exchange is selective, contextual and regulated.

When spatial organisation breaks down

Changes in microbial localisation can be biologically important even when broad community composition changes relatively little.

Increased proximity of bacteria to the epithelium has been described in inflammatory contexts, and disruption of mucus architecture can increase microbial access to host tissue.⁹,²⁵

The consequence is not determined by microbial presence alone.

Host response matters.

Epithelial condition matters.

The organisms involved matter.

The duration and extent of contact matter.

This again argues against reducing barrier dysfunction to a binary state.

A change in spatial organisation can alter the intensity and character of host–microbial signalling before catastrophic tissue failure occurs.

The interface can become dysregulated without disappearing.

Faecal microbiota and mucosal microbiota answer different questions

Most large human microbiome studies use stool samples.

This is understandable and often appropriate.

But stool is not a biopsy of the mucosal interface.

Studies comparing luminal and mucosa-associated communities have demonstrated differences in microbial composition and spatial distribution.⁶,⁷

Faecal sampling may therefore be particularly useful for studying distal luminal ecology and for large-scale longitudinal sampling.

Mucosal sampling addresses different questions about microorganisms located closer to host tissue.

Neither is universally superior.

The correct sample depends on the biological question.

If the hypothesis concerns microbial interaction with the epithelial surface, the distance between the sample and the proposed mechanism becomes part of the study design.

The host also selects its microbiota

Microbiome discussions often emphasise what microbes do to the host.

The relationship runs in both directions.

Host genetics, immunity, mucus composition, epithelial metabolism, bile acids, intestinal transit and diet all influence microbial niches.¹³,¹⁷,²⁶,²⁷

The host therefore participates in selecting the microbial community that develops.

This is not complete control.

Microbial transmission, environmental exposure, stochastic processes and microbial competition also matter.

But the microbial ecosystem is partly constructed within conditions created by the host.

A microbial signature can therefore contain information about host physiology.

It may be an effect as well as a cause.

Host–microbial communication can be protective

The microbiota is frequently discussed in relation to disease, but microbial sensing is also required for normal development and homeostasis.

Microbial signals contribute to maturation and regulation of the immune system, epithelial function and colonisation resistance.¹³,²⁸,²⁹

Commensal microorganisms can occupy ecological niches that might otherwise be available to pathogens, compete for nutrients and produce compounds that inhibit other organisms.²⁹

The host, in turn, can promote containment and tolerance of beneficial or harmless microbial communities.

This reciprocal relationship is one reason why eliminating microbial exposure is not a meaningful model of intestinal health.

The objective is regulated coexistence.

The interface connects ecology with physiology

The intestinal interface is where microbial ecology becomes host physiology.

A change in microbial composition matters biologically when it changes the signals, substrates or interactions reaching the host.

A change in host physiology matters ecologically when it changes the environment available to microorganisms.

The two systems are therefore coupled.

This coupling makes causal interpretation difficult, but it also makes the intestinal interface scientifically important.

It is where microbial composition, microbial function, epithelial biology and immune regulation meet.

My own work: microbial change within a barrier context

This relationship between microbial ecology and barrier biology has been central to my own experimental work.

In wild-type and zonulin-transgenic mice, we examined the effects of bovine colostrum on intestinal microbiota and behaviour within a model in which barrier regulation differed genetically.³⁰

The microbial findings were therefore not interpreted in isolation.

They existed within an experimental system involving host genotype, intestinal-barrier regulation and behavioural outcomes.

Our subsequent transcriptomic study examined intestinal host responses in the same broader model and identified changes involving tight-junction and inflammatory signalling pathways.³¹

These studies do not establish a simple linear sequence in which one microbial change produced one host outcome.

They illustrate something more biologically realistic:

microbial and host responses can occur together within a regulated interface.

Understanding the relationship requires evidence from both sides.

From separation to communication

The intestinal interface is often described using the language of defence.

Defence is part of its function.

But it is not the whole of it.

Mucus creates spatial organisation.

Antimicrobial molecules shape microbial niches.

Secretory antibodies regulate microbial contact.

Epithelial cells sense microbial products.

Immune cells distinguish context.

Microbial metabolites influence host physiology.

Host metabolism changes microbial habitat.

The interface is therefore neither an open door nor an impermeable wall.

It is a site of controlled biological exchange.

That is why microbial ecology cannot be understood only from the lumen, and barrier biology cannot be understood only from the host.

The intestinal interface is where two living systems meet — not by eliminating contact, but by regulating it.

References

  1. Johansson MEV, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(39):15064–15069. doi:10.1073/pnas.0803124105.
  2. Johansson MEV, Hansson GC. Immunological aspects of intestinal mucus and mucins. Nature Reviews Immunology. 2016;16(10):639–649. doi:10.1038/nri.2016.88.
  3. Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nature Reviews Immunology. 2014;14(3):141–153. doi:10.1038/nri3608.
  4. Allaire JM, Crowley SM, Law HT, Chang SY, Ko HJ, Vallance BA. The intestinal epithelium: central coordinator of mucosal immunity. Trends in Immunology. 2018;39(9):677–696. doi:10.1016/j.it.2018.04.002.
  5. Eshleman EM, Alenghat T. Epithelial sensing of microbiota-derived signals. Genes & Immunity. 2021;22(5–6):237–246. doi:10.1038/s41435-021-00124-w.
  6. Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans ADL, de Vos WM. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Applied and Environmental Microbiology. 2002;68(7):3401–3407. doi:10.1128/AEM.68.7.3401-3407.2002.
  7. Tang Q, Jin G, Wang G, Liu T, Liu X, Wang B, Cao H. Current sampling methods for gut microbiota: a call for more precise devices. Frontiers in Cellular and Infection Microbiology. 2020;10:151. doi:10.3389/fcimb.2020.00151.
  8. Tailford LE, Crost EH, Kavanaugh D, Juge N. Mucin glycan foraging in the human gut microbiome. Frontiers in Genetics. 2015;6:81. doi:10.3389/fgene.2015.00081.
  9. Desai MS, Seekatz AM, Koropatkin NM, et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell. 2016;167(5):1339–1353.e21. doi:10.1016/j.cell.2016.10.043.
  10. Goto Y. Epithelial cells as a transmitter of signals from commensal bacteria and host immune cells. Frontiers in Immunology. 2019;10:2057. doi:10.3389/fimmu.2019.02057.
  11. Pabst O, Slack E. IgA and the intestinal microbiota: the importance of being specific. Mucosal Immunology. 2020;13(1):12–21. doi:10.1038/s41385-019-0227-4.
  12. Yang C, Mogno I, Contijoch EJ, et al. Fecal IgA levels are determined by strain-level differences in Bacteroides ovatus and are modifiable by gut microbiota manipulation. Cell Host & Microbe. 2020;27(3):467–475.e6. doi:10.1016/j.chom.2020.01.016.
  13. Honda K, Littman DR. The microbiota in adaptive immune homeostasis and disease. Nature. 2016;535(7610):75–84. doi:10.1038/nature18848.
  14. Yao Y, Shang W, Bao L, et al. Epithelial-immune cell crosstalk for intestinal barrier homeostasis. European Journal of Immunology. 2024;54(6):e2350631. doi:10.1002/eji.202350631.
  15. Bevins CL, Salzman NH. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nature Reviews Microbiology. 2011;9(5):356–368. doi:10.1038/nrmicro2546.
  16. Gallo RL, Hooper LV. Epithelial antimicrobial defence of the skin and intestine. Nature Reviews Immunology. 2012;12(7):503–516. doi:10.1038/nri3228.
  17. Byndloss MX, Olsan EE, Rivera-Chávez F, et al. Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion. Science. 2017;357(6351):570–575. doi:10.1126/science.aam9949.
  18. Litvak Y, Byndloss MX, Tsolis RM, Bäumler AJ. Dysbiotic Proteobacteria expansion: a microbial signature of epithelial dysfunction. Current Opinion in Microbiology. 2017;39:1–6. doi:10.1016/j.mib.2017.07.003.
  19. Kelly CJ, Zheng L, Campbell EL, et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host & Microbe. 2015;17(5):662–671. doi:10.1016/j.chom.2015.03.005.
  20. Rivera-Chávez F, Zhang LF, Faber F, et al. Depletion of butyrate-producing Clostridia from the gut microbiota drives an aerobic luminal expansion of Salmonella. Cell Host & Microbe. 2016;19(4):443–454. doi:10.1016/j.chom.2016.03.004.
  21. Winter SE, Winter MG, Xavier MN, et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science. 2013;339(6120):708–711. doi:10.1126/science.1232467.
  22. Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332–1345. doi:10.1016/j.cell.2016.05.041.
  23. Wahlström A, Sayin SI, Marschall HU, Bäckhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metabolism. 2016;24(1):41–50. doi:10.1016/j.cmet.2016.05.005.
  24. Agus A, Clément K, Sokol H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut. 2021;70(6):1174–1182. doi:10.1136/gutjnl-2020-323071.
  25. Chassaing B, Koren O, Goodrich JK, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015;519(7541):92–96. doi:10.1038/nature14232.
  26. Donaldson GP, Lee SM, Mazmanian SK. Gut biogeography of the bacterial microbiota. Nature Reviews Microbiology. 2016;14(1):20–32. doi:10.1038/nrmicro3552.
  27. Tropini C, Earle KA, Huang KC, Sonnenburg JL. The gut microbiome: connecting spatial organization to function. Cell Host & Microbe. 2017;21(4):433–442. doi:10.1016/j.chom.2017.03.010.
  28. Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121–141. doi:10.1016/j.cell.2014.03.011.
  29. Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against intestinal pathogens. Nature Reviews Immunology. 2013;13(11):790–801. doi:10.1038/nri3535.
  30. Asbjornsdottir B, Miranda-Ribera A, Fiorentino M, Konno T, Cetinbas M, Lan J, Sadreyev RI, Gudmundsson LS, Gottfredsson M, Lauth B, Birgisdottir BE, Fasano A. Prophylactic effect of bovine colostrum on intestinal microbiota and behavior in wild-type and zonulin transgenic mice. Biomedicines. 2023;11(1):91. doi:10.3390/biomedicines11010091.
  31. Asbjornsdottir B, Sigurdsson S, Miranda-Ribera A, et al. Evaluating prophylactic effect of bovine colostrum on intestinal barrier function in zonulin transgenic mice: a transcriptomic study. International Journal of Molecular Sciences. 2023;24(19):14730. doi:10.3390/ijms241914730.

Authorship & AI Transparency — This work is entirely my own. AI-assisted tools are used solely for language review and clarity. I disclose their use in the interest of transparency and research integrity and take full responsibility for the final published work.

Verified peer-reviewed records

Prophylactic Effect of Bovine Colostrum on Intestinal Microbiota and Behavior in Wild-Type and Zonulin Transgenic Mice

Biomedicines · 2023

Perspective · Living Boundaries · Aug 24, 2026

The intestinal barrier is not a wall.

Living Boundaries concerns the health of communication: how a boundary receives, sets limits and adapts according to context. The intestinal barrier is the biological starting point for that larger question.